Macrophage-specific overexpression of antimicrobial peptide PR-39 inhibits intracellular growth of Salmonella enterica serovar Typhimurium in macrophage cells

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 315-321

  Wen, Yang An ^a   Yu, Xiao Lin ^a   Xia, Qian Feng ^a   Cen, Dong ^a   Liu, Jin Bo ^a   Tu, Zhi Guang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Antimicrobial peptides; Intracellular bacteria; Macrophage; PR 39

Indexed keywords

ADENOVIRUS VECTOR; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; PR 39;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CELL SPECIFICITY; CELL STRAIN COS7; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; EMBRYO; EUKARYOTE; GENE INSERTION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; MACROPHAGE; MELANOMA B16; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM;

ADENOVIRIDAE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; HUMANS; MACROPHAGES; MICE; PLASMIDS; SALMONELLA TYPHIMURIUM; TRANSFECTION; UP-REGULATION;

EID: 67849121307     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.04.014     Document Type: Article

References (19)

1. Leemans J.C., Thepen T., Weijer S., Florquin S., van Rooijen N., van de Winkel J.G., et al. Macrophages play a dual role during pulmonary tuberculosis in mice. J Infect Dis 191 (2005) 65-74
2. Mookherjee N., and Hancock R.E.W. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64 (2007) 922-933
3. Shi J.S., Ross C.R., Leto T.L., and Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. Proc Natl Acad Sci USA 93 (1996) 6014-6018
4. Sang Y., and Blecha F. Porcine host defense peptides: expanding repertoire and functions. Dev Comp Immunol 33 (2009) 334-343
5. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75 (2004) 39-48
6. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117 (2001) 91-97
7. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., López-Boado Y.S., Stratman J.L., et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286 (1999) 113-117
8. Agerbert B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V., et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202 (1991) 849-854
9. Shi J.S., Ross C.R., Chengappa M.M., Sylte M.J., Mcvey D.S., and Blecha F. Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide. Antimicrob Agents Chemother 40 (1996) 115-121
10. Linde C.M.A., Hoffner S.E., Refai E., and Andersson M. In vitro activity of PR-39, a proline-arginine-rich peptide against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 47 (2001) 575-580
11. Huang H.J., Ross C.R., and Blecha F. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J Leukoc Biol 61 (1997) 624-629
12. Li J., Post M., Volk R., Gao Y., Li M., Metais C., et al. PR39, a peptide regulator of angiogenesis. Nat Med 6 (2000) 49-55 Erratum. Nat Med 2000;6:356
13. Luo J., Deng Z.L., Luo X., Tang N., Song X.X., Chen J., et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2 (2007) 1236-1247
14. Ross C.R., Ricevuti G., and Scovassi A.L. The antimicrobial peptide PR-39 has a protective effect against HeLa cell apoptosis. Chem Biol Drug Des 70 (2007) 154-157
15. Wu J., Parungo C., Wu G., Kang P.M., Laham R.J., Sellke F.W., et al. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2. Circulation 109 (2004) 1660-1667
16. Lee P.H.A., Ohtake T., Zaiou M., Murakami M., Rudisill J.A., Lin K.H., et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci USA 102 (2005) 3750-3755
17. Whitman S.C., Rateri D.L., Szilvassy S.J., Cornicelli J.A., and Daugherty A. Macrophage-specific expression of class A scavenger receptors in LDL receptor-/- mice decreases atherosclerosis and changes spleen morphology. J Lipid Res 43 (2002) 1201-1208
18. Ferreira V., van Dijk K.W., Groen A.K., Vos R.M., van der Kaa J., Gijbels M.J., et al. Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation. Atherosclerosis 192 (2007) 283-290
19. He W.J., Qiang M., Ma W.Q., Valente A.J., Quinones M.P., Wang W., et al. Development of a synthetic promoter for macrophage gene therapy. Hum Gene Ther 17 (2006) 949-959